Polycystic Ovary Syndrome (PCOS)

Focused Ultrasound Therapy

Early Stage squareFocused ultrasound is an early-stage, noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with polycystic ovarian syndrome (PCOS). This novel technology focuses beams of ultrasound energy precisely and accurately on targets deep in the body without damaging surrounding normal tissue. Where the beams converge, the ultrasound produces precise ablation (thermal destruction of tissue) enabling PCOS to be treated without surgery. The use of focused ultrasound to ablate aberrant ovarian tissue will require further research before it can be readily available.

The primary options for treatment of PCOS include medication, but it may require surgery.

For certain patients, focused ultrasound could provide a noninvasive alternative to surgery with less risk of complications and lower cost.

Advantages:

  • Focused ultrasound is noninvasive, so it does not carry added concerns like surgical wound healing or infection.
  • Focused ultrasound can reach the desired target without damaging surrounding tissue.
  • It can be repeated, if necessary.

Clinical Trials

At the present time, there are no clinical trials recruiting patients for focused ultrasound treatment of PCOS.

Regulatory Approval and Reimbursement

Focused ultrasound treatment for PCOS is not yet approved by regulatory bodies or covered by medical insurance companies.

Notable Papers

Shehata IA, Ballard JR, Casper AJ, Hennings LJ, Cressman E, Ebbini ES. High-intensity focused ultrasound for potential treatment of polycystic ovary syndrome: toward a noninvasive surgery. Fertil Steril. 2014 Feb;101(2):545-51.

Moussatov AG, Baker AC, Duck FA. A possible approach to the treatment of polycystic ovarian syndrome using focused ultrasound. Ultrasonics. 1998 Jul;36(8):893-900.

Click here for additional references from PubMed.